BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 31269423)

  • 21. Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events.
    Bertrand RL
    Med Hypotheses; 2017 Apr; 101():69-74. PubMed ID: 28351498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD36 pumps fat to defang killer T cells in tumors.
    Subramanian M; Marelli-Berg FM
    Cell Metab; 2021 Aug; 33(8):1509-1511. PubMed ID: 34348095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of baicalein as a ferroptosis inhibitor by natural product library screening.
    Xie Y; Song X; Sun X; Huang J; Zhong M; Lotze MT; Zeh HJ; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 May; 473(4):775-780. PubMed ID: 27037021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy.
    Latunde-Dada GO
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1893-1900. PubMed ID: 28552631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.
    Skoupilová H; Michalová E; Hrstka R
    Klin Onkol; 2018; 31(Suppl 2):21-26. PubMed ID: 31023020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ironing-Out the Details: New Strategies for Combining Ferroptosis Inhibitors with Immunotherapy in Melanoma.
    Emmons MF; Smalley KSM
    J Invest Dermatol; 2022 Jan; 142(1):18-20. PubMed ID: 34565560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron and ferroptosis: A still ill-defined liaison.
    Doll S; Conrad M
    IUBMB Life; 2017 Jun; 69(6):423-434. PubMed ID: 28276141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis is a lysosomal cell death process.
    Gao H; Bai Y; Jia Y; Zhao Y; Kang R; Tang D; Dai E
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1550-1556. PubMed ID: 30031610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.
    Yang WS; Kim KJ; Gaschler MM; Patel M; Shchepinov MS; Stockwell BR
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E4966-75. PubMed ID: 27506793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
    Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 and CD8 T lymphocyte interplay in controlling tumor growth.
    Ostroumov D; Fekete-Drimusz N; Saborowski M; Kühnel F; Woller N
    Cell Mol Life Sci; 2018 Feb; 75(4):689-713. PubMed ID: 29032503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.
    Fanzani A; Poli M
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28783123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral Tcf1
    Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
    Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity.
    Peng W; McKenzie JA; Hwu P
    Cancer Discov; 2016 Sep; 6(9):953-5. PubMed ID: 27587467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
    Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of ferroptosis on cancers, activation and deactivation by various therapeutic candidates-an update.
    Nguyen THP; Mahalakshmi B; Velmurugan BK
    Chem Biol Interact; 2020 Feb; 317():108930. PubMed ID: 31866335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ferroptosis pathway and its intervention regulated by Chinese materia medica].
    Xu WH; Li CH; Jiang TL
    Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(20):4019-4026. PubMed ID: 30486525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(2):838-44. PubMed ID: 27510639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferroptosis in cancer and cancer immunotherapy.
    Zhao L; Zhou X; Xie F; Zhang L; Yan H; Huang J; Zhang C; Zhou F; Chen J; Zhang L
    Cancer Commun (Lond); 2022 Feb; 42(2):88-116. PubMed ID: 35133083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.